The microbiota-gut-brain axis — where diet shapes gut bacteria, which influence peptide hormone release (CCK, GLP-1, PYY), which signal the brain to regulate appetite — offers multiple targets for obesity treatment.
3 key peptide hormones orchestrate satietyCCK, GLP-1, and PYY form the core signaling system linking diet, gut bacteria, and brain appetite centers through the microbiota-gut-brain axis
What the researchers found
Three gut peptide hormones — CCK, GLP-1, and PYY — serve as the primary signaling molecules in the satiety system, released by enteroendocrine cells (EECs) in response to specific macronutrients detected through nutrient-sensing receptors. The gut microbiota directly interacts with EECs and modulates hormone release by changing the gut environment and producing metabolites. Diet shapes the microbiome, which shapes hormone release, which shapes brain appetite signals — creating the microbiota-gut-brain axis (MGBA). The review proposes that bioactive compounds exploiting these nutrient-sensing mechanisms could become functional foods or drugs for obesity.
Why it matters
Obesity affects over 650 million adults worldwide and current treatments are limited. Understanding the natural signaling system that controls appetite — from the food we eat to the bacteria in our gut to the hormones that tell our brain we're full — reveals multiple intervention points. Rather than targeting a single receptor (as GLP-1 drugs do), future therapies could work through functional foods that optimize the entire microbiota-gut-brain axis.
The numbers in context
CCK, GLP-1, PYY as key satiety hormones; enteroendocrine cells; microbiota-gut-brain axis; organ-on-a-chip models
How the study worked
Narrative review covering the biology of gut peptide satiety hormones (CCK, GLP-1, PYY), enteroendocrine cell nutrient-sensing mechanisms, the role of the intestinal microbiota in modulating these systems, and the microbiota-gut-brain axis. Also discusses organ-on-a-chip technology as a platform for modeling multi-organ communication and testing potential bioactive compounds.
Who was studied
Review of gut-brain signaling literature (no study population)
What this study cannot tell us
This is a broad conceptual review without new experimental data. Many proposed mechanisms are based on animal studies and may not translate to humans. The gut microbiome-satiety connection in humans is still poorly defined. Organ-on-a-chip technology is promising but not yet validated for predicting human appetite responses. The review doesn't address the practical challenges of designing functional foods with reliable bioactive compound delivery.
How to read the evidence
This is a broad narrative review synthesizing basic science and translational literature. It provides a useful conceptual framework but doesn't present new data or use systematic review methodology. Much of the microbiome-satiety evidence is from animal studies.
When this study was published
Published in 2021, this review predates the widespread clinical adoption of GLP-1 drugs for obesity but anticipated the importance of gut peptide hormone systems in appetite regulation.
The bigger picture
The success of GLP-1 drugs has validated the gut peptide hormone approach to obesity treatment. This review zooms out to show that GLP-1 is just one part of a larger system involving multiple hormones, the gut microbiome, and dietary inputs. As the field moves toward combination peptide therapies (GLP-1 + GIP, or GLP-1 + PYY), understanding the full microbiota-gut-brain axis becomes essential. Functional foods that optimize this entire system could eventually complement or even replace some pharmaceutical interventions.
Questions still open
- Could specific dietary interventions that optimize gut microbiome composition enhance natural GLP-1 and PYY release enough to aid weight loss?
- Would functional foods targeting nutrient-sensing receptors on enteroendocrine cells provide clinically meaningful appetite suppression?
- Can organ-on-a-chip models accurately predict how dietary bioactive compounds will affect human satiety hormone release?
Common questions
How do gut hormones control appetite?
Can changing your diet or gut bacteria help control hunger?
Read the original research
A Review on the Role of Food-Derived Bioactive Molecules and the Microbiota-Gut-Brain Axis in Satiety Regulation.
Nutrients, 13(2)
Citation
Pizarroso, Nuria A; Fuciños, Pablo; Gonçalves, Catarina; Pastrana, Lorenzo; Amado, Isabel R. (2021). A Review on the Role of Food-Derived Bioactive Molecules and the Microbiota-Gut-Brain Axis in Satiety Regulation.. Nutrients, 13(2). https://doi.org/10.3390/nu13020632